Clinical Trial Update: Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial comparing olanzapine to an active comparator for Bipolar I Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Active comparator (unspecified)
• olanzapine (olanzapine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Bipolar Disorder | Phase 4 | Status: COMPLETED